Tyson Ruetz is a Senior Scientist at AbCellera, where they develop and implement high throughput screening techniques for antibody engineering and development. They co-founded ReneuBio, leveraging their postdoctoral research at Stanford, where they developed an in vitro genome-wide screening platform and an in vivo CRISPR-Cas9 functional screening platform focused on rejuvenating neural stem cells. Tyson earned a PhD in Stem Cells from The University of Edinburgh, contributing significant advancements in the understanding of aging and neurogenesis through their research.
This person is not in the org chart
This person is not in any teams
This person is not in any offices